A listed North American firm needed support with the identification of early-stage in-licensing or acquisition opportunities in the highly competitive field of regenerative medicine. Alacrita was engaged to perform the search.


We conducted a scouting exercise for late-stage academic or seed-/early-stage commercial programs in the field of regenerative stem cell therapies. By leveraging our extensive network in academia and early-stage private companies, we were able to introduce our client to a number of opportunities that were not previously known to them nor were they yet listed in syndicated licensing databases. The client then conducted its own detailed assessment of these opportunities.

Related Case Studies